Johnson Matthey (OTCMKTS:JMPLY) Lifted to Buy at Zacks Investment Research

Wednesday, April 7, 2021 | MarketBeat

Johnson Matthey (OTCMKTS:JMPLY) was upgraded by Zacks Investment Research from a "hold" rating to a "buy" rating in a report released on Wednesday, Zacks.com reports. The brokerage currently has a $95.00 price target on the basic materials company's stock. Zacks Investment Research's price objective suggests a potential upside of 10.57% from the stock's previous close.

According to Zacks, "Johnson Matthey Plc is a speciality chemicals company focused on its core skills in catalysis, precious metals, fine chemicals and process technology. Its principal activities comprise manufacture of autocatalysts, heavy duty diesel catalysts and pollution control systems, catalysts and components for fuel cells, catalysts and technologies for chemical processes, fine chemicals, chemical catalysts and active pharmaceutical ingredients. The Company also engages in the marketing, refining, and fabrication of precious metals. Its environmental technologies include emission control technologies, process technologies and fuel cells. Its precious metals products include platinum, noble metals, catalysts, chemicals and refining and colour technologies. Its fine chemicals include macfarlan smith, pharmaceutical materials and services and research chemicals. Johnson Matthey Plc is headquartered in London, U.K. "

Several other equities research analysts have also weighed in on JMPLY. Morgan Stanley reissued an "overweight" rating on shares of Johnson Matthey in a report on Friday, February 5th. Credit Suisse Group reaffirmed an "outperform" rating on shares of Johnson Matthey in a report on Wednesday, March 10th. Stifel Nicolaus reiterated a "hold" rating on shares of Johnson Matthey in a research report on Tuesday, March 9th. Deutsche Bank Aktiengesellschaft reiterated a "hold" rating on shares of Johnson Matthey in a research report on Tuesday, March 2nd. Finally, Jefferies Financial Group started coverage on Johnson Matthey in a research report on Monday, March 29th. They set a "buy" rating for the company. Three equities research analysts have rated the stock with a sell rating, four have issued a hold rating and six have given a buy rating to the company. The company presently has a consensus rating of "Hold" and a consensus price target of $95.00.

JMPLY traded up $0.97 during trading hours on Wednesday, hitting $85.92. The stock had a trading volume of 2,245 shares, compared to its average volume of 1,792. The company's fifty day simple moving average is $87.02 and its 200 day simple moving average is $72.41. Johnson Matthey has a 1 year low of $44.21 and a 1 year high of $94.45. The stock has a market cap of $8.31 billion, a PE ratio of 16.95, a price-to-earnings-growth ratio of 6.11 and a beta of 1.58.

About Johnson Matthey

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.

Recommended Story: Management Fee

Get a free copy of the Zacks research report on Johnson Matthey (JMPLY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Johnson Matthey (OTCMKTS:JMPLY)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]



7 Great Dividend Stocks to Buy For a Comfortable Retirement

There are people who will say the day of set it and forget it retirement accounts are over. But it’s a narrative we’ve heard before. The truth is the formula for saving for and enjoying a comfortable retirement, like the formula for weight loss, hasn’t really changed. A lot depends on whether an individual has the discipline to see it through.

Dividend stocks remain one of the core elements of a retirement portfolio. As individuals near retirement the ability to reinvest dividends allows for a greater total return. And once individuals need to live off their portfolio, the dividends provide a source of income without having to tap their principal.

However, not all dividend stocks are the same and many investors get sucked in by the allure of a high-yield dividend stock. But what you’re really looking for are companies with a history of increasing its dividend. The ability to increase a dividend over time illustrates that the company has a business model that can hold up regardless of how the broader economy is performing.

In this special presentation, we’ll highlight seven stocks that individuals can buy today to capture a stable, recurring dividend.

View the "7 Great Dividend Stocks to Buy For a Comfortable Retirement".


MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.